Ordinary Index Re-Weighting in the Solactive Europe & US Top Pharmaceuticals 2020 AR 5% Index | September 2020

In the ordinary re-weighting the following composition will be implemented effective open 01.10.2020:

ABBVIE INC
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB CO
JOHNSON & JOHNSON
MERCK & CO. INC.
NOVARTIS AG
NOVO NORDISK A/S
PFIZER INC
ROCHE HOLDING AG
SANOFI SA